{"id":467067,"date":"2025-12-23T17:42:33","date_gmt":"2025-12-23T17:42:33","guid":{"rendered":"https:\/\/www.europesays.com\/us\/467067\/"},"modified":"2025-12-23T17:42:33","modified_gmt":"2025-12-23T17:42:33","slug":"uta-texas-am-tees-open-biomanufacturing-training-and-research-hub-at-pegasus-park-dallas-innovates","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/us\/467067\/","title":{"rendered":"UTA, Texas A&M TEES Open Biomanufacturing Training and Research Hub at Pegasus Park \u00bb Dallas Innovates"},"content":{"rendered":"

\"\"<\/p>\n

Ribbon-cutting ceremony for the National Center for Therapeutics Manufacturing satellite campus [Photo: UTA]<\/p>\n

UTA and the Texas A&M Engineering Experiment Station have opened a new biomanufacturing training and research hub at Pegasus Park focused on workforce training and early-stage biotech development.<\/strong><\/p>\n

The National Center for Therapeutics Manufacturing satellite campus, or NCTM2, offers hands-on training, state-of-the-art lab space and support for early-stage biotech companies. It sits inside Bridge Labs, the two-story, 135,000-square-foot facility that\u2019s quickly become a key life sciences asset in Dallas.<\/p>\n

At the opening, UTA President Jennifer Cowley framed the investment as a long-term workforce play designed to connect education, research, and commercialization. <\/p>\n

\u201cTogether, we are strengthening the biomanufacturing workforce and expanding access to hands-on training,\u201d Cowley said. \u201cWe\u2019re also creating pathways for students, researchers, and entrepreneurs to bring lifesaving innovations from concept to market.\u201d<\/p>\n

She said the goal is to help North Texas compete for biotech talent as demand for advanced manufacturing skills continues to rise.<\/p>\n

\"\"<\/p>\n

UTA President Jennifer Cowley at NCTM2 [Photo: UTA]<\/p>\n

A statewide partnership built for workforce growth<\/p>\n

NCTM2 is a joint effort between UTA\u2019s Institute for Biomanufacturing and Precision Medicine of North Texas and Texas A&M Engineering Experiment Station, or TEES. The collaboration brings together engineering depth, biomanufacturing expertise, and biomedical research to address workforce gaps identified by life sciences companies across the state.<\/p>\n

Rodney Bowersox, deputy director of TEES\u2014a state research agency within the Texas A&M focused on conducting applied engineering research to drive innovation and economic benefit\u2014said the partnership allows each institution to contribute its strongest capabilities.\u00a0<\/p>\n

\u201cBy linking our strengths in engineering and biomanufacturing with UTA\u2019s leadership in biomedical innovation, we\u2019re building a training ecosystem that is broader, stronger, and more agile than anything we could build alone,\u201d Bowersox said.<\/p>\n

Demand for workers with bioprocessing and good manufacturing practice (GMP) experience continues to grow, particularly as the U.S. works to expand domestic production of vaccines, therapeutics, and other biologics, according to the partners. Regional training hubs like NCTM2 are expected to play a central role in meeting that demand.<\/p>\n

Labs and tools for biotech startups in Dallas-Fort Worth<\/p>\n

Startups, in particular, often face challenges finding affordable lab space or access to biomanufacturing tools, and with NCTM2, those companies have another option to grow locally.<\/p>\n

Dallas City Councilwoman Laura Cadena said the partnership helps keep innovation and manufacturing rooted locally.<\/p>\n

\u201cBy expanding biomanufacturing capacity and accelerating the development of new medical technologies in partnership with Texas A&M Engineering Experiment Station, UTA is helping ensure that lifesaving innovations are created\u2014and deployed\u2014right here in our community,\u201d Cadena said.<\/p>\n

She said the work also supports local hospitals and care providers while bringing new technologies closer to patients.<\/p>\n

Positioning North Texas for the next era of therapeutics<\/p>\n

Jon Weidanz, UTA\u2019s senior associate vice president for research and founding director of the university\u2019s Institute of Biomanufacturing and Precision Medicine for North Texas, or IMPRINT, said the initiative lays groundwork for future growth.<\/p>\n

The new satellite campus aligns with national efforts to strengthen the U.S. bioeconomy and accelerate production of next-generation medicines. And in North Texas, it reinforces the region\u2019s role at the intersection of research, training, and industry, according to the partners.<\/p>\n

\u201cWe are proud to bring IMPRINT\u2019s expertise in precision medicine, synthetic biology, and translational therapeutics to this transformative partnership,\u201d Weidanz said. \u201cTogether, we are building the backbone of Texas\u2019 next-generation biomanufacturing ecosystem and positioning North Texas as a national leader to produce the medicines of the future.\u201d<\/p>\n

Don\u2019t miss what\u2019s next. Subscribe\u00a0to\u00a0Dallas\u00a0Innovates.<\/p>\n

Track Dallas-Fort Worth\u2019s business and innovation landscape with our curated news in your inbox Tuesday-Thursday.<\/p>\n

\u00a0<\/p>\n

\tR E A D\u00a0\u00a0 N E X T\t<\/p>\n